Life Sciences and Health Care | Deloitte Malta | Global services, reports, and industry insights
Life Sciences and Health Care

Life Sciences and Health Care

The Life Sciences and Health Care industry group strives to support clients in addressing the challenges that impact today’s industry. Deloitte member firms' global network engages with clients to develop innovative solutions to help them achieve their business missions.


Join the conversation

Social media connections to Deloitte's LSHC practice


Deloitte Malta social media

Connect with us on LinkedIn, Facebook, Twitter, YouTube and more!


Life at Deloitte

People make Deloitte one of the best places to work. What’s great about the people? That’s an easy answer. They are exceptional. Each person is unique and valued for that, among the best and brightest in the business, and takes pride in his or her achievements and the success of others.


Financial Times & Deloitte Digital Health Summit USA

Key figures from throughout the healthcare, technology, and investment arena will come together to set the agenda for overcoming the barriers towards a sustainable digital transition of U.S. healthcare.


Deloitte Analytics

Life Sciences and Healthcare

Learn how Deloitte member firms are helping organizations link business strategy to advanced analytical techniques to improve decision-making capabilities.

About us

Making an impact that matters

Deloitte strives to make an impact that matters. Learn more about some of the ways Deloitte’s network of member firms make an impact around the world.


TMT Predictions 2015

The 2015 edition of Deloitte’s predictions for the technology, media, and telecommunications (TMT) sectors reveal the perspectives gained from hundreds of conversations with industry leaders, and tens of thousands of consumer interviews across the globe. Review the predictions here.


DTTL Competitiveness Series

Read Deloitte’s global competitiveness series to learn about the sectors projected to drive a country’s next wave of domestic prosperity

Contact us

Contact us via our online form.


Raphael Aloisio

Financial Advisory Leader



Measuring the return from pharmaceutical innovation 2014

The fifth annual study of the pharmaceutical industry’s performance in generating a return from its significant investment in R&D. The report allows industry leaders to understand the drivers of successful R&D strategies that are tangible and, most importantly, actionable.


2014 global risk survey

What’s your company’s reputation worth? More than 300 business executives from around the world say a company’s reputation is a priceless asset that should be protected as if it’s a matter of life and death, because from a business and career perspective, that’s exactly what it is.